Tech Company Financing Transactions

CoLucid Pharmaceuticals Funding Round

CoLucid Pharmaceuticals secured a $13.8 million financing round on 3/31/2010. Backers included Care Capital and Domain Associates.

Transaction Overview

Announced On
3/31/2010
Transaction Type
Venture Equity
Amount
$13,800,000
Round
Undisclosed
Investors

Care Capital (Richard Markham)

Domain Associates (Jesse Treu)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
P.O. Box 425227
Cambridge, MA 02142
USA
Email Address
Overview
CoLucid Pharma is a biotech company focusing on therapies for CNS disorders, Migraine, sleep/wake disorders, chronic pain, Alzheimers, and psychiatric disorders.
Profile
CoLucid Pharmaceuticals LinkedIn Company Profile
Social Media
CoLucid Pharmaceuticals Company Twitter Account
Company News
CoLucid Pharmaceuticals News
Facebook
CoLucid Pharmaceuticals on Facebook
YouTube
CoLucid Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Mathers
  Thomas Mathers LinkedIn Profile  Thomas Mathers Twitter Account  Thomas Mathers News  Thomas Mathers on Facebook
Chief Financial Officer
Matthew Dallas
  Matthew Dallas LinkedIn Profile  Matthew Dallas Twitter Account  Matthew Dallas News  Matthew Dallas on Facebook
VP - Bus. Development
Linda Hogan
  Linda Hogan LinkedIn Profile  Linda Hogan Twitter Account  Linda Hogan News  Linda Hogan on Facebook
VP - General Counsel
Daniel Boeglin
  Daniel Boeglin LinkedIn Profile  Daniel Boeglin Twitter Account  Daniel Boeglin News  Daniel Boeglin on Facebook
VP - R & D
Nadia Rupniak
  Nadia Rupniak LinkedIn Profile  Nadia Rupniak Twitter Account  Nadia Rupniak News  Nadia Rupniak on Facebook
VP - Regulatory Affairs
Bernice Kuca
  Bernice Kuca LinkedIn Profile  Bernice Kuca Twitter Account  Bernice Kuca News  Bernice Kuca on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2010: M2 Group Holdings venture capital transaction
Next: 3/31/2010: Exegy venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary